Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000459204> ?p ?o ?g. }
- W2000459204 endingPage "715.e1" @default.
- W2000459204 startingPage "710" @default.
- W2000459204 abstract "Objectives To compare the effectiveness of a mixture of acacia fiber, psyllium fiber, and fructose (AFPFF) with polyethylene glycol 3350 combined with electrolytes (PEG+E) in the treatment of children with chronic functional constipation (CFC); and to evaluate the safety and effectiveness of AFPFF in the treatment of children with CFC. Study design This was a randomized, open label, prospective, controlled, parallel-group study involving 100 children (M/F: 38/62; mean age ± SD: 6.5 ± 2.7 years) who were diagnosed with CFC according to the Rome III Criteria. Children were randomly divided into 2 groups: 50 children received AFPFF (16.8 g daily) and 50 children received PEG+E (0.5 g/kg daily) for 8 weeks. Primary outcome measures were frequency of bowel movements, stool consistency, fecal incontinence, and improvement of other associated gastrointestinal symptoms. Safety was assessed with evaluation of clinical adverse effects and growth measurements. Results Compliance rates were 72% for AFPFF and 96% for PEG+E. A significant improvement of constipation was seen in both groups. After 8 weeks, 77.8% of children treated with AFPFF and 83% of children treated with PEG+E had improved (P = .788). Neither PEG+E nor AFPFF caused any clinically significant side effects during the entire course of the study period. Conclusions In this randomized study, we did not find any significant difference between the efficacy of AFPFF and PEG+E in the treatment of children with CFC. Both medications were proved to be safe for CFC treatment, but PEG+E was better accepted by children. To compare the effectiveness of a mixture of acacia fiber, psyllium fiber, and fructose (AFPFF) with polyethylene glycol 3350 combined with electrolytes (PEG+E) in the treatment of children with chronic functional constipation (CFC); and to evaluate the safety and effectiveness of AFPFF in the treatment of children with CFC. This was a randomized, open label, prospective, controlled, parallel-group study involving 100 children (M/F: 38/62; mean age ± SD: 6.5 ± 2.7 years) who were diagnosed with CFC according to the Rome III Criteria. Children were randomly divided into 2 groups: 50 children received AFPFF (16.8 g daily) and 50 children received PEG+E (0.5 g/kg daily) for 8 weeks. Primary outcome measures were frequency of bowel movements, stool consistency, fecal incontinence, and improvement of other associated gastrointestinal symptoms. Safety was assessed with evaluation of clinical adverse effects and growth measurements. Compliance rates were 72% for AFPFF and 96% for PEG+E. A significant improvement of constipation was seen in both groups. After 8 weeks, 77.8% of children treated with AFPFF and 83% of children treated with PEG+E had improved (P = .788). Neither PEG+E nor AFPFF caused any clinically significant side effects during the entire course of the study period. In this randomized study, we did not find any significant difference between the efficacy of AFPFF and PEG+E in the treatment of children with CFC. Both medications were proved to be safe for CFC treatment, but PEG+E was better accepted by children." @default.
- W2000459204 created "2016-06-24" @default.
- W2000459204 creator A5007559655 @default.
- W2000459204 creator A5013454365 @default.
- W2000459204 creator A5016693591 @default.
- W2000459204 creator A5028966942 @default.
- W2000459204 creator A5041476083 @default.
- W2000459204 creator A5058702991 @default.
- W2000459204 creator A5068677663 @default.
- W2000459204 creator A5068773464 @default.
- W2000459204 creator A5081156006 @default.
- W2000459204 creator A5091255858 @default.
- W2000459204 date "2012-10-01" @default.
- W2000459204 modified "2023-10-01" @default.
- W2000459204 title "A Randomized, Prospective, Comparison Study of a Mixture of Acacia Fiber, Psyllium Fiber, and Fructose vs Polyethylene Glycol 3350 with Electrolytes for the Treatment of Chronic Functional Constipation in Childhood" @default.
- W2000459204 cites W1622285696 @default.
- W2000459204 cites W172591799 @default.
- W2000459204 cites W1967016549 @default.
- W2000459204 cites W1968486555 @default.
- W2000459204 cites W1968527829 @default.
- W2000459204 cites W1973328055 @default.
- W2000459204 cites W1994971197 @default.
- W2000459204 cites W1999580880 @default.
- W2000459204 cites W2015683722 @default.
- W2000459204 cites W2026277522 @default.
- W2000459204 cites W2028024674 @default.
- W2000459204 cites W2043029415 @default.
- W2000459204 cites W2050368620 @default.
- W2000459204 cites W2058556767 @default.
- W2000459204 cites W2061983344 @default.
- W2000459204 cites W2069909494 @default.
- W2000459204 cites W2073032289 @default.
- W2000459204 cites W2073559568 @default.
- W2000459204 cites W2089130161 @default.
- W2000459204 cites W2104587001 @default.
- W2000459204 cites W2105831596 @default.
- W2000459204 cites W2106345021 @default.
- W2000459204 cites W2115012443 @default.
- W2000459204 cites W211930448 @default.
- W2000459204 cites W2125665617 @default.
- W2000459204 cites W2131385868 @default.
- W2000459204 cites W2138334282 @default.
- W2000459204 cites W2148085720 @default.
- W2000459204 cites W2151296144 @default.
- W2000459204 cites W2152423168 @default.
- W2000459204 cites W2153804076 @default.
- W2000459204 cites W277114675 @default.
- W2000459204 cites W4205204214 @default.
- W2000459204 cites W4205948440 @default.
- W2000459204 doi "https://doi.org/10.1016/j.jpeds.2012.04.043" @default.
- W2000459204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22677568" @default.
- W2000459204 hasPublicationYear "2012" @default.
- W2000459204 type Work @default.
- W2000459204 sameAs 2000459204 @default.
- W2000459204 citedByCount "34" @default.
- W2000459204 countsByYear W20004592042012 @default.
- W2000459204 countsByYear W20004592042013 @default.
- W2000459204 countsByYear W20004592042014 @default.
- W2000459204 countsByYear W20004592042015 @default.
- W2000459204 countsByYear W20004592042016 @default.
- W2000459204 countsByYear W20004592042017 @default.
- W2000459204 countsByYear W20004592042018 @default.
- W2000459204 countsByYear W20004592042019 @default.
- W2000459204 countsByYear W20004592042020 @default.
- W2000459204 countsByYear W20004592042021 @default.
- W2000459204 countsByYear W20004592042022 @default.
- W2000459204 countsByYear W20004592042023 @default.
- W2000459204 crossrefType "journal-article" @default.
- W2000459204 hasAuthorship W2000459204A5007559655 @default.
- W2000459204 hasAuthorship W2000459204A5013454365 @default.
- W2000459204 hasAuthorship W2000459204A5016693591 @default.
- W2000459204 hasAuthorship W2000459204A5028966942 @default.
- W2000459204 hasAuthorship W2000459204A5041476083 @default.
- W2000459204 hasAuthorship W2000459204A5058702991 @default.
- W2000459204 hasAuthorship W2000459204A5068677663 @default.
- W2000459204 hasAuthorship W2000459204A5068773464 @default.
- W2000459204 hasAuthorship W2000459204A5081156006 @default.
- W2000459204 hasAuthorship W2000459204A5091255858 @default.
- W2000459204 hasConcept C10138342 @default.
- W2000459204 hasConcept C108797546 @default.
- W2000459204 hasConcept C126322002 @default.
- W2000459204 hasConcept C127413603 @default.
- W2000459204 hasConcept C141071460 @default.
- W2000459204 hasConcept C162324750 @default.
- W2000459204 hasConcept C168563851 @default.
- W2000459204 hasConcept C188816634 @default.
- W2000459204 hasConcept C197934379 @default.
- W2000459204 hasConcept C2776964284 @default.
- W2000459204 hasConcept C2779642851 @default.
- W2000459204 hasConcept C2780661987 @default.
- W2000459204 hasConcept C2781112942 @default.
- W2000459204 hasConcept C42360764 @default.
- W2000459204 hasConcept C54400483 @default.
- W2000459204 hasConcept C71924100 @default.
- W2000459204 hasConcept C90924648 @default.
- W2000459204 hasConceptScore W2000459204C10138342 @default.
- W2000459204 hasConceptScore W2000459204C108797546 @default.
- W2000459204 hasConceptScore W2000459204C126322002 @default.